• Je něco špatně v tomto záznamu ?

The MSLT is Repeatable in Narcolepsy Type 1 But Not Narcolepsy Type 2: A Retrospective Patient Study

C. Ruoff, F. Pizza, LM. Trotti, K. Sonka, S. Vandi, J. Cheung, S. Pinto, M. Einen, N. Simakajornboon, F. Han, P. Peppard, S. Nevsimalova, G. Plazzi, D. Rye, E. Mignot,

. 2018 ; 14 (1) : 65-74. [pub] 20180115

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural

Perzistentní odkaz   https://www.medvik.cz/link/bmc19045578

Grantová podpora
K23 NS083748 NINDS NIH HHS - United States
R01 NS089719 NINDS NIH HHS - United States
T32 HL110952 NHLBI NIH HHS - United States

E-zdroje Online Plný text

NLK Free Medical Journals od 2007 do Před 6 měsíci
PubMed Central od 2007 do Před 1 rokem

STUDY OBJECTIVES: To examine repeatability of Multiple Sleep Latency Test (MSLT) results in narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2) according to the criteria of the International Classification of Sleep Disorders, Third Edition (ICSD-3). METHODS: Repeatability of the MSLT was retrospectively evaluated in NT1 (n = 60) and NT2 (n = 54) cases, and controls (n = 15). All subjects had documented HLA-DQB1*06:02 status and/or hypocretin-1 levels from cerebrospinal fluid. All subjects had undergone 2 MSLTs (≥ 1 meeting ICSD-3 criteria for narcolepsy). Repeatability was explored in children versus adults and in those on versus not on medication(s). Subsample and multivariate analysis were performed. RESULTS: Both MSLTs in unmedicated patients were positive for narcolepsy in 78%, 18%, and 7% of NT1, NT2, and controls, respectively. NT2 cases changed to idiopathic hypersomnia or to a negative MSLT 26% and 57% of the time, respectively. Although NT1 cases were 10 to 14 times more likely to demonstrate a second positive MSLT compared to NT2 cases (P < 10-5) and controls (P < 10-4), respectively, NT2 cases were not significantly different from controls (P = .64). Medication use (P = .009) but not adult versus children status (P = .85) significantly decreased the likelihood of a repeat positive MSLT. CONCLUSIONS: In a clinical setting, a positive MSLT for narcolepsy is a more reproducible and stable feature in NT1 than NT2. The retrospective design of this study hinders interpretation of these data, as there are many different, and possibly opposing, reasons to repeat a MSLT in NT1 versus NT2 (ie, ascertainment bias). Additional systematic MSLT repeatability studies independent of confounds are ideally needed to confirm these findings.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045578
003      
CZ-PrNML
005      
20200115084651.0
007      
ta
008      
200109s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.5664/jcsm.6882 $2 doi
035    __
$a (PubMed)29198301
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ruoff, Chad $u Center for Sleep Sciences and Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, California.
245    14
$a The MSLT is Repeatable in Narcolepsy Type 1 But Not Narcolepsy Type 2: A Retrospective Patient Study / $c C. Ruoff, F. Pizza, LM. Trotti, K. Sonka, S. Vandi, J. Cheung, S. Pinto, M. Einen, N. Simakajornboon, F. Han, P. Peppard, S. Nevsimalova, G. Plazzi, D. Rye, E. Mignot,
520    9_
$a STUDY OBJECTIVES: To examine repeatability of Multiple Sleep Latency Test (MSLT) results in narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2) according to the criteria of the International Classification of Sleep Disorders, Third Edition (ICSD-3). METHODS: Repeatability of the MSLT was retrospectively evaluated in NT1 (n = 60) and NT2 (n = 54) cases, and controls (n = 15). All subjects had documented HLA-DQB1*06:02 status and/or hypocretin-1 levels from cerebrospinal fluid. All subjects had undergone 2 MSLTs (≥ 1 meeting ICSD-3 criteria for narcolepsy). Repeatability was explored in children versus adults and in those on versus not on medication(s). Subsample and multivariate analysis were performed. RESULTS: Both MSLTs in unmedicated patients were positive for narcolepsy in 78%, 18%, and 7% of NT1, NT2, and controls, respectively. NT2 cases changed to idiopathic hypersomnia or to a negative MSLT 26% and 57% of the time, respectively. Although NT1 cases were 10 to 14 times more likely to demonstrate a second positive MSLT compared to NT2 cases (P < 10-5) and controls (P < 10-4), respectively, NT2 cases were not significantly different from controls (P = .64). Medication use (P = .009) but not adult versus children status (P = .85) significantly decreased the likelihood of a repeat positive MSLT. CONCLUSIONS: In a clinical setting, a positive MSLT for narcolepsy is a more reproducible and stable feature in NT1 than NT2. The retrospective design of this study hinders interpretation of these data, as there are many different, and possibly opposing, reasons to repeat a MSLT in NT1 versus NT2 (ie, ascertainment bias). Additional systematic MSLT repeatability studies independent of confounds are ideally needed to confirm these findings.
650    _2
$a dospělí $7 D000328
650    _2
$a věkové faktory $7 D000367
650    _2
$a dítě $7 D002648
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a narkolepsie $x diagnóza $7 D009290
650    _2
$a polysomnografie $x metody $x statistika a číselné údaje $7 D017286
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a senzitivita a specificita $7 D012680
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
700    1_
$a Pizza, Fabio $u IRCCS Istituto delle Scienze Neurologiche, ASL di Bologna, Bologna, Italy. Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
700    1_
$a Trotti, Lynn Marie $u Department of Neurology, Emory Sleep Center, Emory University School of Medicine, Atlanta, Georgia.
700    1_
$a Sonka, Karel $u Department of Neurology, 1st Medical Faculty, Charles University, Prague, Czeck Republic.
700    1_
$a Vandi, Stefano $u IRCCS Istituto delle Scienze Neurologiche, ASL di Bologna, Bologna, Italy. Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
700    1_
$a Cheung, Joseph $u Center for Sleep Sciences and Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, California.
700    1_
$a Pinto, Swaroop $u Sleep Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Division of Pulmonology and Sleep Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
700    1_
$a Einen, Mali $u Center for Sleep Sciences and Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, California.
700    1_
$a Simakajornboon, Narong $u Sleep Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Division of Pulmonology and Sleep Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
700    1_
$a Han, Fang $u Department of Pulmonary Medicine, Peking University People's Hospital, Beijing, China.
700    1_
$a Peppard, Paul $u Department of Preventive Medicine, University of Madison Wisconsin, Madison, Wisconsin.
700    1_
$a Nevsimalova, Sona $u Department of Neurology, 1st Medical Faculty, Charles University, Prague, Czeck Republic.
700    1_
$a Plazzi, Giuseppe $u IRCCS Istituto delle Scienze Neurologiche, ASL di Bologna, Bologna, Italy. Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
700    1_
$a Rye, David $u Department of Neurology, Emory Sleep Center, Emory University School of Medicine, Atlanta, Georgia.
700    1_
$a Mignot, Emmanuel $u Center for Sleep Sciences and Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, California.
773    0_
$w MED00188111 $t Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine $x 1550-9397 $g Roč. 14, č. 1 (2018), s. 65-74
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29198301 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200115085024 $b ABA008
999    __
$a ok $b bmc $g 1483846 $s 1084251
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 14 $c 1 $d 65-74 $e 20180115 $i 1550-9397 $m Journal of clinical sleep medicine $n J Clin Sleep Med $x MED00188111
GRA    __
$a K23 NS083748 $p NINDS NIH HHS $2 United States
GRA    __
$a R01 NS089719 $p NINDS NIH HHS $2 United States
GRA    __
$a T32 HL110952 $p NHLBI NIH HHS $2 United States
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...